Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Akero Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 113 | 146 | +33 |
| Shares | 36.7M | 46.7M | +10.0M (+27.2%) |
| Value | $329.6M | $1.59B | +$1.26B (+381.9%) |
New holders (49)
Institutions that held Akero Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Akero Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 2,300,000 | $21.7M |
| Millennium Management LLC | 520,769 | $4.92M |
| Cormorant Asset Management, LP | 403,787 | $3.82M |
| Federated Hermes, Inc. | 128,087 | $1.21M |
| Bank of Montreal | 69,653 | $769.0K |
| Karp Capital Management Corp | 35,000 | $331.0K |
| Engineers Gate Manager LP | 28,899 | $273.0K |
| Dynamic Technology Lab Private Ltd | 28,155 | $266.0K |
| Two Sigma Advisers, LP | 22,200 | $210.0K |
| Martingale Asset Management L P | 15,316 | $145.0K |
| XTX Topco Ltd | 13,305 | $126.0K |
| HSBC Holdings PLC | 13,064 | $124.0K |
| Quantbot Technologies LP | 10,100 | $95.0K |
| Point72 Hong Kong Ltd | 398 | $4.00K |
| Captrust Financial Advisors | 53 | $1.00K |
| CoreCap Advisors, LLC | 50 | $0 |